반응식
[CH3:1][S:2][C:3]1[C:4]2[CH:27]=[CH:26][NH:25][C:5]=2[N:6]=[C:7]([NH:9][C:10]2[CH:15]=[CH:14][C:13]([N:16]3[CH2:21][CH2:20][N:19]([C:22](=[O:24])[CH3:23])[CH2:18][CH2:17]3)=[CH:12][CH:11]=2)[N:8]=1.C1C=C(Cl)C=C(C(OO)=[O:36])C=1>C(Cl)Cl>[CH3:1][S:2]([C:3]1[C:4]2[CH:27]=[CH:26][NH:25][C:5]=2[N:6]=[C:7]([NH:9][C:10]2[CH:11]=[CH:12][C:13]([N:16]3[CH2:21][CH2:20][N:19]([C:22](=[O:24])[CH3:23])[CH2:18][CH2:17]3)=[CH:14][CH:15]=2)[N:8]=1)=[O:36]참가 물질
4
실험 절차
To a solution of 1-(4-(4-(4-(methylthio)-7H-pyrrolo[2,3-d]pyrimidin-2-ylamino)phenyl)piperazin-1-yl)ethanone (451 mg, 1.18 mmol) in CH2Cl2 (12 mL), mCPBA (320 mg, 65%, 1.20 mmol) was added. The mixture was stirred at room temperature for 1 h. It was then concentrated in vacuo, the residue was purified by HPLC to give 1-(4-(4-(4-(methylsulfinyl)-7H-pyrrolo[2,3-d]pyrimidin-2-ylamino)phenyl)piperazin-1-yl)ethanone as a solid (136 mg).
후처리
- concentrationIt was then concentrated in vacuo
- customthe residue was purified by HPLC
출처 및 근거
- ORD 기록
- ord-71d32c31a9a445d5b323f3550d5ebf27
- 출처 데이터셋
- uspto-grants-2015_09
- 특허 번호
- US09139581B2
연결된 노트
불러오는 중…